31 Mar 2022
Assets36.84
Total Income44.98
Profit After Tax3.35
NET Worth16.38
Reserves and Surplus10.47
Total Borrowing12.24
Open · Close · Listing
Onyx Biotec is a SME IPO with an issue size of ₹29.34 crore, proposed for listing on NSE SME. The issue structure includes a fresh issue of ₹27.85 crore.
| Object | Amount |
|---|---|
| Upgradation of existing manufacturing Unit I to manufacture large volume parentals for intravenous use; | ₹6.08 Cr |
| Setting up a high-speed cartooning packaging line at existing manufacturing Unit II for Dry Powder Injections; | ₹1.24 Cr |
| Prepayment or repayment of all or a portion of certain loans availed by the Company; and | ₹12.00 Cr |
| General Corporate Purposes | ₹6.00 Cr |
| KPI | May 31, 2024 |
|---|---|
| ROE | 4.99% |
| ROCE | 3.71% |
| Debt / Equity | 1.21% |
| RoNW | 4.99% |
| PAT Margin | 12.42% |
| Price to Book Value | 3.1 |
| Expense | Amount |
|---|---|
| Issue management fees including fees and reimbursements of Market Making fees and payment to other Intermediaries such as Legal Advisors to the IPO, Registrars and other out of pocket expenses. | ₹1.26 Cr |
| Marketing and Selling Commission and expenses | ₹2.45 Cr |
| Advertising and marketing expenses | ₹0.16 Cr |
| Printing and distribution of issue stationery | ₹0.01 Cr |
| Listing fees | ₹0.01 Cr |
| SEBI and NSE processing fees | ₹0.00 Cr |
| Book Building software fees | ₹0.04 Cr |
| Other regulatory expenses | ₹0.05 Cr |
| Miscellaneous | ₹0.05 Cr |